These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 23507819

  • 1. Every cloud has a silver lining: a case of simultaneously appropriate and inappropriate implantable cardioverter defibrillator shock.
    Capulzini L, Mazzotta G, Sorgente A.
    Europace; 2013 Nov; 15(11):1683. PubMed ID: 23507819
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inappropriate implantable cardioverter-defibrillator shock induced by electromagnetic interference while taking a shower.
    Fernengel A, Schwer C, Helber U, Dörnberger V.
    Clin Res Cardiol; 2007 Jun; 96(6):393-5. PubMed ID: 17453136
    [No Abstract] [Full Text] [Related]

  • 4. Inappropriate discharge of an implantable cardioverter defibrillator during atrial flutter and intermittent ventricular antibradycardia pacing.
    Peters W, Kowallik P, Wittenberg G, Scholl C, Meesmann M.
    J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1167-74. PubMed ID: 9363821
    [Abstract] [Full Text] [Related]

  • 5. Minimizing inappropriate or "unnecessary" implantable cardioverter-defibrillator shocks: appropriate programming.
    Koneru JN, Swerdlow CD, Wood MA, Ellenbogen KA.
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):778-90. PubMed ID: 22010117
    [No Abstract] [Full Text] [Related]

  • 6. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ, MADIT II Investigators.
    J Am Coll Cardiol; 2008 Apr 08; 51(14):1357-65. PubMed ID: 18387436
    [Abstract] [Full Text] [Related]

  • 7. Effect of implantable cardioverter-defibrillator shocks on QT dispersion.
    Gurevitz O, Yaacoby E, Segal E, Perel A, Eldar M, Kaplinsky E, Glikson M.
    Am J Cardiol; 2000 Nov 15; 86(10):1146-8, A9. PubMed ID: 11074218
    [Abstract] [Full Text] [Related]

  • 8. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A, Yoshida Y, Nakano Y, Kihara Y.
    Int J Cardiol; 2013 Oct 15; 168(6):5273-6. PubMed ID: 23988302
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Implantable cardioverter-defibrillator shocks: a double-edged sword?
    Raitt MH.
    J Am Coll Cardiol; 2008 Apr 08; 51(14):1366-8. PubMed ID: 18387437
    [No Abstract] [Full Text] [Related]

  • 11. Images in clinical medicine. Shock delivered by an implantable cardioverter-defibrillator in response to spontaneous ventricular fibrillation.
    Roelke M, O'Nunain SS.
    N Engl J Med; 1995 Mar 30; 332(13):860. PubMed ID: 7870141
    [No Abstract] [Full Text] [Related]

  • 12. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F, Probst V, Maury P, Babuty D, Mansourati J, Komatsu Y, Marquie C, Rosa A, Diallo A, Cassagneau R, Loizeau C, Martins R, Field ME, Derval N, Miyazaki S, Denis A, Nogami A, Ritter P, Gourraud JB, Ploux S, Rollin A, Zemmoura A, Lamaison D, Bordachar P, Pierre B, Jaïs P, Pasquié JL, Hocini M, Legal F, Defaye P, Boveda S, Iesaka Y, Mabo P, Haïssaguerre M.
    Circulation; 2013 Oct 15; 128(16):1739-47. PubMed ID: 23995538
    [Abstract] [Full Text] [Related]

  • 13. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event? A case report].
    Krzyzanowski K, Michałkiewicz D, Wierzbowski R, Gniłka A, Ryczek R, Orski Z, Kubik L.
    Kardiol Pol; 2009 Aug 15; 67(8):927-9. PubMed ID: 19784895
    [Abstract] [Full Text] [Related]

  • 14. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T, Köditz H, Niehaus M, Paul T, Tebbenjohanns J.
    Pacing Clin Electrophysiol; 2004 Jul 15; 27(7):924-32. PubMed ID: 15271011
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy.
    Bhavnani SP, Coleman CI, White CM, Clyne CA, Yarlagadda R, Guertin D, Kluger J.
    Europace; 2008 Jul 15; 10(7):854-9. PubMed ID: 18495672
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Atrial fibrillation and flutter in children and young adults with congenital cardiopathies].
    Gow RM.
    Can J Cardiol; 1996 Feb 15; 12 Suppl A():43A-48A. PubMed ID: 8673952
    [No Abstract] [Full Text] [Related]

  • 19. Supraventricular arrhythmia induction by an implantable cardioverter defibrillator in a patient with hypertrophic cardiomyopathy.
    Akbarzadeh F, Kazemi B, Pourafkari L.
    Pacing Clin Electrophysiol; 2010 Mar 15; 33(3):372-6. PubMed ID: 19744274
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.